Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 2,703,287 3.700% |
-1,229,946 (-31.27%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | uniQure N.V. QURE |
PFM Health Sciences, LP | 2,302,314 4.900% |
-90,997 (-3.80%) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
PFM Health Sciences, LP | 4,459,783 7.300% |
367,474 (+8.98%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Erasca, Inc. ERAS |
PFM Health Sciences, LP | 4,797,460 3.200% |
-2,953,028 (-38.10%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
PFM Health Sciences, LP | 1,391,831 3.200% |
-767,902 (-35.56%) |
Filing History |
| 2023-02-14 4:06 pm Unchanged |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 3,844,332 8.700% |
0 (Unchanged) |
Filing History |
| 2023-01-17 4:01 pm Purchase |
2023-01-06 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 1,821,820 5.300% |
528,527 (+40.87%) |
Filing History |
| 2023-01-17 1:20 pm Sale |
2022-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 1,293,293 4.200% |
-223,733 (-14.75%) |
Filing History |
| 2022-11-10 4:02 pm Purchase |
2022-10-31 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 3,844,332 8.700% |
3,844,332 (New Position) |
Filing History |
| 2022-10-24 4:01 pm Purchase |
2022-10-14 | 13G | Axsome Therapeutics, Inc. AXSM |
PFM Health Sciences, LP | 2,159,733 5.400% |
2,159,733 (New Position) |
Filing History |
| 2022-10-17 4:01 pm Purchase |
2022-10-06 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 3,933,233 5.500% |
502,223 (+14.64%) |
Filing History |
| 2022-09-06 4:02 pm Purchase |
2022-08-26 | 13G | Erasca, Inc. ERAS |
PFM Health Sciences, LP | 7,750,488 6.300% |
7,750,488 (New Position) |
Filing History |
| 2022-09-06 4:01 pm Purchase |
2022-08-25 | 13G | Generation Bio Co. GBIO |
PFM Health Sciences, LP | 3,013,712 5.100% |
3,013,712 (New Position) |
Filing History |
| 2022-07-18 4:11 pm Purchase |
2022-07-07 | 13G | uniQure N.V. QURE |
PFM Health Sciences, LP | 2,393,311 5.100% |
2,393,311 (New Position) |
Filing History |
| 2022-06-17 4:21 pm Purchase |
2022-06-07 | 13G | Praxis Precision Medicines, Inc. PRAX |
PFM Health Sciences, LP | 165,302 5.400% |
165,302 (New Position) |
Filing History |
| 2022-05-09 4:51 pm Purchase |
2022-04-28 | 13G | Adaptimmune Therapeutics plc ADAP |
PFM Health Sciences, LP | 54,658,680 5.800% |
54,658,680 (New Position) |
Filing History |
| 2022-05-02 4:02 pm Purchase |
2022-04-21 | 13G | Werewolf Therapeutics, Inc. HOWL |
PFM Health Sciences, LP | 1,517,026 5.500% |
1,517,026 (New Position) |
Filing History |
| 2022-04-25 4:48 pm Purchase |
2022-04-13 | 13G | IO Biotech, Inc. IOBT |
PFM Health Sciences, LP | 1,510,136 5.200% |
1,510,136 (New Position) |
Filing History |
| 2022-02-14 12:39 pm Sale |
2021-12-31 | 13G | Aerie Pharmaceuticals, Inc. AERI |
PFM Health Sciences, LP | 1,088,566 2.300% |
-1,725,797 (-61.32%) |
Filing History |
| 2022-02-14 12:39 pm Purchase |
2021-12-31 | 13G | Outset Medical, Inc. OM |
PFM Health Sciences, LP | 196,017 6.200% |
1,937 (+1.00%) |
Filing History |